文献速递主动脉疾病

无症状肾下腹主动脉瘤生长速度及影响因素:单中心监测队列数据库分析

How Quickly Do Asymptomatic Infrarenal Abdominal Aortic Aneurysms Grow and What Factors Affect Aneurysm Growth Rates? Analysis of a Single Centre Surveillance Cohort Database.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-09-04

该研究回顾性分析单中心20年腹主动脉瘤监测数据库,共纳入692例患者、5363次AAA测量。结果显示平均增长率为2.3 mm/年,女性增长率更高,糖尿病患者增长率更低;仅3.9%患者发生破裂,死亡者中多数死于恶性肿瘤而非AAA。

要点

  • 平均AAA增长率为2.3 mm/年,女性增长更快,糖尿病者增长更慢。
  • 11%患者在最大前后径<30 mm时仍被监测,需优化监测准入。
  • 监测中破裂率仅3.9%,死亡者多数死于恶性肿瘤。

核心结论

  • AAA监测中平均增长率为2.3 mm/年,女性增长率更高,糖尿病者增长率更低。
  • 需避免对因年龄或合并症 unlikely 接受手术的患者继续监测,并及时终止监测。

研究设计与样本

  • 单中心AAA监测数据库20年回顾性分析,共分析692例患者的5363次AAA测量。

主要发现

  • 平均AAA增长率为2.3 mm/年。
  • 20.1%患者接受择期修复,需手术者增长率显著更快。
  • 监测中仅3.9%患者发生破裂,其中40.7%末次扫描最大前后径<55 mm。
  • 214例死亡中仅11.7%与AAA相关,多数死于恶性肿瘤。
  • 入组时最大前后径>40 mm或年增长>4 mm者更可能接受手术;女性增长率显著更高,糖尿病者显著更低。

关键数值与推荐

  • 11%(n=73)患者在最大前后径<30 mm时仍被监测。
  • 最大前后径>40 mm或年增长>4 mm与接受手术显著相关。
  • 其他合并症及用药史与AAA增长或5年、10年无手术生存无显著关联。

临床怎么用

  • 对因年龄或合并症极不可能进展至手术指征者,不应继续AAA监测。
  • 当患者进展至手术可能性极低时,应及时从监测中退出。
  • 女性AAA患者增长更快,监测中需关注。

局限性

  • 回顾性单中心数据库分析,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/BACKGROUND: Abdominal aortic aneurysm (AAA) maximum antero-posterior diameter (MAPD) is the parameter most commonly used to inform the timing of surgical intervention. However, other factors, such as growth rates and patient comorbidities are likely to be important considerations as they may influence AAA related complications including rupture, operative outcomes, and the clinical and cost effectiveness of continued surveillance. METHODS: This was a retrospective analysis of a 20 year period of a single centre AAA surveillance database. In total, 5363 AAA measurements in 692 patients were analysed for patient demographics, including comorbidity and drug history, growth and rupture rates, and cause of death. RESULTS: A significant proportion of patients (n = 73; 11%) were kept under surveillance despite having a MAPD < 30 mm. Overall, mean aneurysm growth rate was 2.3 mm/year. Elective repair was undertaken in 20.1% and those who required surgical intervention had significantly faster growth rates. Only 3.9% of patients in surveillance ruptured, 40.7% of whom had a MAPD <55 mm at their last scan. Of the 214 deaths recorded, only 11.7% were related to AAA. The majority of patients who died in surveillance did so from malignancy. Patients with larger AAA (MAPD > 40 mm) on entry into surveillance were significantly more likely to receive surgical intervention, as were those whose AAA expanded >4 mm/year. Females had significantly higher growth rates, and those with diabetes had significantly smaller growth rates. Other comorbidities and drug history were not associated with AAA growth, or 5 and 10 year surgery free survival. CONCLUSION: The results highlight several areas for service improvement. Specifically, it is important not to maintain surveillance in patients who are very unlikely to ever grow to a point where AAA surgery would be contemplated on grounds or age and/or comorbidity. Similarly, patients should be discharged from surveillance when this likelihood becomes apparent.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ahmad M, Mistry R, Hodson J, et al. How Quickly Do Asymptomatic Infrarenal Abdominal Aortic Aneurysms Grow and What Factors Affect Aneurysm Growth Rates? Analysis of a Single Centre Surveillance Cohort Database. Eur J Vasc Endovasc Surg. 2017. PMID: 28882515. doi:10.1016/j.ejvs.2017.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。